Heska Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $93.81
- Today's High:
- $98.37
- Open Price:
- $94.95
- 52W Low:
- $57.83
- 52W High:
- $149.17
- Prev. Close:
- $94.4
- Volume:
- 210233
Company Statistics
- Market Cap.:
- $1.04 billion
- Book Value:
- 38.987
- Revenue TTM:
- $257.31 million
- Operating Margin TTM:
- -8.02%
- Gross Profit TTM:
- $111.17 million
- Profit Margin:
- -7.73%
- Return on Assets TTM:
- -2.17%
- Return on Equity TTM:
- -4.64%
Company Profile
Heska Corporation had its IPO on 1997-06-30 under the ticker symbol HSKA.
The company operates in the Healthcare sector and Medical Devices industry. Heska Corporation has a staff strength of 808 employees.
Stock update
Shares of Heska Corporation opened at $94.95 at the start of the last trading session i.e. 2023-03-30.
The stocks traded within a range of $93.81 - $98.37, and closed at $97.35.
This is a +3.13% increase from the previous day's closing price.
A total volume of 210,233 shares were traded at the close of the day’s session.
In the last one week, shares of Heska Corporation have increased by +9.76%.
Heska Corporation's Key Ratios
Heska Corporation has a market cap of $1.04 billion, indicating a price to book ratio of 1.7376 and a price to sales ratio of 2.5957.
In the last 12-months Heska Corporation’s revenue was $257.31 million with a gross profit of $111.17 million and an EBITDA of $-6673000. The EBITDA ratio measures Heska Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Heska Corporation’s operating margin was -8.02% while its return on assets stood at -2.17% with a return of equity of -4.64%.
In Q4, Heska Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a negative 2.5%.
Heska Corporation’s PE and PEG Ratio
- Forward PE
- 62.5
- Trailing PE
- 0
- PEG
- 2.53
Its diluted EPS in the last 12-months stands at $-1.94 per share while it has a forward price to earnings multiple of 62.5 and a PEG multiple of 2.53. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Heska Corporation’s profitability.
Heska Corporation stock is trading at a EV to sales ratio of 2.5207 and a EV to EBITDA ratio of -885.9472. Its price to sales ratio in the trailing 12-months stood at 2.5957.
Heska Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $585.82 million
- Total Liabilities
- $39.58 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $514000
- Dividend Payout Ratio
- 0%
Heska Corporation ended 2023 with $585.82 million in total assets and $0 in total liabilities. Its intangible assets were valued at $585.82 million while shareholder equity stood at $422.21 million.
Heska Corporation ended 2023 with $0 in deferred long-term liabilities, $39.58 million in other current liabilities, 108000.00 in common stock, $-168533000.00 in retained earnings and $135.92 million in goodwill. Its cash balance stood at $156.62 million and cash and short-term investments were $156.62 million. The company’s total short-term debt was $2,944,000 while long-term debt stood at $95.60 million.
Heska Corporation’s total current assets stands at $265.03 million while long-term investments were $3.96 million and short-term investments were $7.43 million. Its net receivables were $36.93 million compared to accounts payable of $16.40 million and inventory worth $60.05 million.
In 2023, Heska Corporation's operating cash flow was $0 while its capital expenditure stood at $514000.
Comparatively, Heska Corporation paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $97.35
- 52-Week High
- $149.17
- 52-Week Low
- $57.83
- Analyst Target Price
- $106.4
Heska Corporation stock is currently trading at $97.35 per share. It touched a 52-week high of $149.17 and a 52-week low of $149.17. Analysts tracking the stock have a 12-month average target price of $106.4.
Its 50-day moving average was $86.42 and 200-day moving average was $80.42 The short ratio stood at 5.44 indicating a short percent outstanding of 0%.
Around 629.4% of the company’s stock are held by insiders while 9647.4% are held by institutions.
Frequently Asked Questions About Heska Corporation
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.